首页 > 最新文献

Rambam Maimonides Medical Journal最新文献

英文 中文
Changes in the Management of Common Bile Duct Stones: 1980 to Date. 胆总管结石治疗的变化:1980年至今。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-28 DOI: 10.5041/RMMJ.10521
Ruth Stalnikowicz, Jochanan Benbassat

Objective: To compare the results of treating patients with common bile duct (CBD) stones by endoscopic sphincterotomy (ES), surgical exploration, or a combination of ES and surgical CBD exploration (the rendezvous technique).

Methods: A narrative review of the literature.

Summary of data: Before 1990, 17 cohort studies indicated that ES cleared CBD stones in 92.0% of patients, with a mortality rate of 1.5%. Surgery removed CBD stones in 90.2% of patients, with a 2.1% mortality rate. A single randomized controlled trial in 1987 showed that ES removed CBD stones in 91% of 55 patients, with a 3.6% mortality rate and a 27% complication rate, whereas surgical CBD exploration removed CBD stones in 92%, with a 1.8% mortality rate and a 22% complication rate. Since 1991, 26 randomized controlled trials have shown that laparoscopic-ES rendezvous is as effective as ES alone and laparoscopic surgery alone but is associated with fewer complications, a reduced need for additional procedures, and a shorter hospital stay.

Conclusions: A laparoscopic-ES rendezvous appears to be the optimal approach to the treatment of CBD stones in younger and fit patients. The choice between ES alone and laparoscopic-ES rendezvous in older or high-risk patients remains uncertain.

目的比较通过内镜括约肌切开术(ES)、外科探查术或内镜括约肌切开术和外科CBD探查术(会合技术)联合治疗胆总管(CBD)结石患者的效果:方法:对文献进行叙述性回顾:1990 年以前,17 项队列研究表明,92.0% 的患者通过 ES 清除了 CBD 结石,死亡率为 1.5%。90.2%的患者通过手术清除了 CBD 结石,死亡率为 2.1%。1987 年的一项随机对照试验显示,在 55 名患者中,91% 的 CBD 结石患者通过 ES 清除了结石,死亡率为 3.6%,并发症发生率为 27%;而通过手术探查 CBD 结石的患者比例为 92%,死亡率为 1.8%,并发症发生率为 22%。自1991年以来,已有26项随机对照试验表明,腹腔镜-ES会合手术与单纯ES手术和单纯腹腔镜手术一样有效,但并发症更少,对额外手术的需求更低,住院时间更短:腹腔镜与腹腔镜联合手术似乎是治疗年轻、体格健壮的CBD结石患者的最佳方法。对于年龄较大或高危患者,在单纯ES和腹腔镜-ES交会术之间如何选择仍不确定。
{"title":"Changes in the Management of Common Bile Duct Stones: 1980 to Date.","authors":"Ruth Stalnikowicz, Jochanan Benbassat","doi":"10.5041/RMMJ.10521","DOIUrl":"10.5041/RMMJ.10521","url":null,"abstract":"<p><strong>Objective: </strong>To compare the results of treating patients with common bile duct (CBD) stones by endoscopic sphincterotomy (ES), surgical exploration, or a combination of ES and surgical CBD exploration (the rendezvous technique).</p><p><strong>Methods: </strong>A narrative review of the literature.</p><p><strong>Summary of data: </strong>Before 1990, 17 cohort studies indicated that ES cleared CBD stones in 92.0% of patients, with a mortality rate of 1.5%. Surgery removed CBD stones in 90.2% of patients, with a 2.1% mortality rate. A single randomized controlled trial in 1987 showed that ES removed CBD stones in 91% of 55 patients, with a 3.6% mortality rate and a 27% complication rate, whereas surgical CBD exploration removed CBD stones in 92%, with a 1.8% mortality rate and a 22% complication rate. Since 1991, 26 randomized controlled trials have shown that laparoscopic-ES rendezvous is as effective as ES alone and laparoscopic surgery alone but is associated with fewer complications, a reduced need for additional procedures, and a shorter hospital stay.</p><p><strong>Conclusions: </strong>A laparoscopic-ES rendezvous appears to be the optimal approach to the treatment of CBD stones in younger and fit patients. The choice between ES alone and laparoscopic-ES rendezvous in older or high-risk patients remains uncertain.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11065094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Current State of Knowledge on Osteoporosis in Holocaust Survivors and Their Descendants. 大屠杀幸存者及其后代骨质疏松症的知识现状。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-28 DOI: 10.5041/RMMJ.10523
Malvina Hoxha, Visar Malaj

Objective: Starvation in early life can cause poor bone health and metabolic aberrations in bone minerals, leading to abnormal bone development. Holocaust survivors have been exposed to starvation and malnutrition before and during World War II. This paper aims to provide the current state of knowledge on the osteoporosis risk in Holocaust survivors and their descendants.

Methods: The PubMed and Scopus databases were searched. Papers that reported original data on the risk of osteoporosis in Holocaust survivors and in their offspring were included in the study.

Results: Ten studies were included in this review. The majority of studies were case-control ones (n=7) versus two self-reported and one longitudinal study. Despite the limited cohort numbers and the small number of studies in the literature, the data showed a potential increased risk of osteoporosis in Holocaust survivors and especially in their descendants.

Conclusions: The review of these studies showed a higher prevalence of osteoporosis among Holocaust survivors and their offspring. Knowledge of the trans-generational inheritance of osteoporosis in the descendants of Holocaust survivors should increase the awareness of primary care health workers on osteoporosis screening and early diagnosis and implementation of preventive measures, including adequate vitamin D and calcium supplementation, and pharmacological treatment.

目的:幼年时期的饥饿会导致骨骼健康状况不佳和骨矿物质代谢异常,从而导致骨骼发育异常。大屠杀幸存者在二战前和二战期间曾遭受饥饿和营养不良。本文旨在提供有关大屠杀幸存者及其后代骨质疏松症风险的最新知识:方法:检索了 PubMed 和 Scopus 数据库。研究纳入了报告大屠杀幸存者及其后代骨质疏松症风险原始数据的论文:本综述共纳入 10 项研究。大多数研究为病例对照研究(7 项),另有两项自我报告研究和一项纵向研究。尽管队列数量有限,文献中的研究数量也不多,但数据显示大屠杀幸存者,尤其是他们的后代患骨质疏松症的风险可能会增加:对这些研究的回顾表明,大屠杀幸存者及其后代的骨质疏松症患病率较高。对大屠杀幸存者后代骨质疏松症跨代遗传的了解,应提高初级保健卫生工作者对骨质疏松症筛查和早期诊断的认识,并实施预防措施,包括适当补充维生素 D 和钙以及药物治疗。
{"title":"The Current State of Knowledge on Osteoporosis in Holocaust Survivors and Their Descendants.","authors":"Malvina Hoxha, Visar Malaj","doi":"10.5041/RMMJ.10523","DOIUrl":"10.5041/RMMJ.10523","url":null,"abstract":"<p><strong>Objective: </strong>Starvation in early life can cause poor bone health and metabolic aberrations in bone minerals, leading to abnormal bone development. Holocaust survivors have been exposed to starvation and malnutrition before and during World War II. This paper aims to provide the current state of knowledge on the osteoporosis risk in Holocaust survivors and their descendants.</p><p><strong>Methods: </strong>The PubMed and Scopus databases were searched. Papers that reported original data on the risk of osteoporosis in Holocaust survivors and in their offspring were included in the study.</p><p><strong>Results: </strong>Ten studies were included in this review. The majority of studies were case-control ones (n=7) versus two self-reported and one longitudinal study. Despite the limited cohort numbers and the small number of studies in the literature, the data showed a potential increased risk of osteoporosis in Holocaust survivors and especially in their descendants.</p><p><strong>Conclusions: </strong>The review of these studies showed a higher prevalence of osteoporosis among Holocaust survivors and their offspring. Knowledge of the trans-generational inheritance of osteoporosis in the descendants of Holocaust survivors should increase the awareness of primary care health workers on osteoporosis screening and early diagnosis and implementation of preventive measures, including adequate vitamin D and calcium supplementation, and pharmacological treatment.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11065091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Artery Surgery: Past, Present, and Future. 冠状动脉手术:过去、现在和未来。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-19 DOI: 10.5041/RMMJ.10515
Elizabeth C Ghandakly, Gabriele M Iacona, Faisal G Bakaeen

Coronary artery bypass grafting (CABG) is the most commonly performed and studied major cardiac operation worldwide. An understanding of the evolution of CABG, including the early days of cardiac surgery, the first bypass operation, continuous improvements in techniques, and streamlining of the operation, is important to inform current trends and future innovations. This article will examine how CABG evolved (from techniques to conduits), describe current trends in the field, and explore what lies on the horizon for the future of CABG.

冠状动脉搭桥术(CABG)是世界上最常进行和研究的大型心脏手术。了解冠状动脉旁路移植术的演变过程,包括心脏外科的早期、首次旁路手术、技术的不断改进以及手术的简化,对于了解当前趋势和未来创新非常重要。本文将探讨 CABG 的演变过程(从技术到导管),描述该领域当前的发展趋势,并探讨 CABG 未来的发展前景。
{"title":"Coronary Artery Surgery: Past, Present, and Future.","authors":"Elizabeth C Ghandakly, Gabriele M Iacona, Faisal G Bakaeen","doi":"10.5041/RMMJ.10515","DOIUrl":"10.5041/RMMJ.10515","url":null,"abstract":"<p><p>Coronary artery bypass grafting (CABG) is the most commonly performed and studied major cardiac operation worldwide. An understanding of the evolution of CABG, including the early days of cardiac surgery, the first bypass operation, continuous improvements in techniques, and streamlining of the operation, is important to inform current trends and future innovations. This article will examine how CABG evolved (from techniques to conduits), describe current trends in the field, and explore what lies on the horizon for the future of CABG.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial Occurrence of Isolated Late-onset Nasolacrimal Duct Obstruction in Two Unrelated Families. 在两个无血缘关系的家族中出现孤立的晚发性鼻泪管阻塞。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-19 DOI: 10.5041/RMMJ.10519
Anat Bahat Dinur, Ortal Buchbut, Libe Gradstein, Baker Elsana, Ofek Freund, Ohad S Birk, Erez Tsumi

Late-onset nasolacrimal duct obstruction (NLDO) as a result of inflammatory processes causing dacryo-stenosis is a common entity affecting mostly women. While a few mechanisms have been suggested as contributors to the expression of NLDO, the trigger for the inflammation remains mostly unknown. Familial predilection for this condition has not been previously reported. We present two families with multiple individuals affected with congenital or late-onset NLDO, describe the signs and symptoms of the affected individuals, and explore their medical history for any contributing factors. Family A, spanning four generations, included 7 female patients affected by late-onset NLDO. Family B, spanning two generations, included 8 individuals affected by either congenital or late-onset NLDO. This case series suggests a familial predisposition to NLDO, apparently with an autosomal dominant inheritance pattern. Further studies are needed to elucidate the molecular basis of this genetic predisposition.

晚期鼻泪管阻塞(NLDO)是炎症过程导致的泪腺增生症的一种常见病,女性患者居多。虽然有一些机制被认为是导致 NLDO 的因素,但炎症的诱因大多仍不清楚。以前还没有报道过这种疾病的家族遗传倾向。我们介绍了两个有多人患有先天性或晚发性 NLDO 的家族,描述了患者的体征和症状,并探究了他们的病史中是否有任何诱发因素。家族 A 共有四代人,其中包括 7 名受晚发性 NLDO 影响的女性患者。家族 B 有两代人,其中 8 人患有先天性或晚发性 NLDO。这一系列病例表明,NLDO 具有家族易感性,显然是常染色体显性遗传模式。要阐明这种遗传易感性的分子基础,还需要进一步的研究。
{"title":"Familial Occurrence of Isolated Late-onset Nasolacrimal Duct Obstruction in Two Unrelated Families.","authors":"Anat Bahat Dinur, Ortal Buchbut, Libe Gradstein, Baker Elsana, Ofek Freund, Ohad S Birk, Erez Tsumi","doi":"10.5041/RMMJ.10519","DOIUrl":"10.5041/RMMJ.10519","url":null,"abstract":"<p><p>Late-onset nasolacrimal duct obstruction (NLDO) as a result of inflammatory processes causing dacryo-stenosis is a common entity affecting mostly women. While a few mechanisms have been suggested as contributors to the expression of NLDO, the trigger for the inflammation remains mostly unknown. Familial predilection for this condition has not been previously reported. We present two families with multiple individuals affected with congenital or late-onset NLDO, describe the signs and symptoms of the affected individuals, and explore their medical history for any contributing factors. Family A, spanning four generations, included 7 female patients affected by late-onset NLDO. Family B, spanning two generations, included 8 individuals affected by either congenital or late-onset NLDO. This case series suggests a familial predisposition to NLDO, apparently with an autosomal dominant inheritance pattern. Further studies are needed to elucidate the molecular basis of this genetic predisposition.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery for Cardiac Arrhythmias: Past, Present, Future. 心律失常手术:过去、现在和未来。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-19 DOI: 10.5041/RMMJ.10516
Stephen D Waterford, Niv Ad

There is a rich history of surgery for cardiac arrhythmias, spanning from atrial fibrillation and Wolff-Parkinson-White syndrome to inappropriate sinus tachycardia and ventricular tachycardia. This review describes the history of these operations, their evolution over time, and the current state of practice. We devote considerable time to the discussion of atrial fibrillation, the most common cardiac arrhythmia addressed by surgeons. We discuss ablation of atrial fibrillation as a stand-alone operation and as a concomitant operation performed at the time of cardiac surgery. We also discuss the emergence of newer procedures to address atrial fibrillation in the past decade, such as the convergent procedure and totally thoracoscopic ablation, and their outcomes relative to historic approaches such as the Cox maze procedure.

心律失常手术的历史悠久,从心房颤动和沃尔夫-帕金森-怀特综合征到不适当窦性心动过速和室性心动过速。这篇综述介绍了这些手术的历史、随时间推移而发生的演变以及目前的实践状况。我们花了大量时间讨论外科医生最常处理的心律失常--心房颤动。我们讨论了心房颤动消融作为独立手术和在心脏手术时同时进行的手术。我们还讨论了过去十年中出现的治疗心房颤动的新手术,如会聚手术和全胸腔镜消融术,以及它们与考克斯迷宫术等历史性方法相比的效果。
{"title":"Surgery for Cardiac Arrhythmias: Past, Present, Future.","authors":"Stephen D Waterford, Niv Ad","doi":"10.5041/RMMJ.10516","DOIUrl":"10.5041/RMMJ.10516","url":null,"abstract":"<p><p>There is a rich history of surgery for cardiac arrhythmias, spanning from atrial fibrillation and Wolff-Parkinson-White syndrome to inappropriate sinus tachycardia and ventricular tachycardia. This review describes the history of these operations, their evolution over time, and the current state of practice. We devote considerable time to the discussion of atrial fibrillation, the most common cardiac arrhythmia addressed by surgeons. We discuss ablation of atrial fibrillation as a stand-alone operation and as a concomitant operation performed at the time of cardiac surgery. We also discuss the emergence of newer procedures to address atrial fibrillation in the past decade, such as the convergent procedure and totally thoracoscopic ablation, and their outcomes relative to historic approaches such as the Cox maze procedure.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally Invasive Pectus Excavatum Correction and Endoscopic Port Access Mitral Valve Surgery. 微创胸大肌矫正术和内窥镜入孔二尖瓣手术。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-19 DOI: 10.5041/RMMJ.10517
Johan van der Merwe, Filip Casselman, Ivan Degrieck, Frank Van Praet

This case study describes the successful short-term outcome of staged minimally invasive pectus excavatum correction and endoscopic mitral valve repair in a patient with severe mitral valve regurgitation and pectus excavatum.

本病例研究描述了一名患有严重二尖瓣反流和鸡胸的患者通过分期微创鸡胸矫正术和内窥镜二尖瓣修复术取得的短期成功。
{"title":"Minimally Invasive Pectus Excavatum Correction and Endoscopic Port Access Mitral Valve Surgery.","authors":"Johan van der Merwe, Filip Casselman, Ivan Degrieck, Frank Van Praet","doi":"10.5041/RMMJ.10517","DOIUrl":"10.5041/RMMJ.10517","url":null,"abstract":"<p><p>This case study describes the successful short-term outcome of staged minimally invasive pectus excavatum correction and endoscopic mitral valve repair in a patient with severe mitral valve regurgitation and pectus excavatum.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Against Over-reliance on PRISMA Guidelines for Meta-analytical Studies. 反对过度依赖《元分析研究 PRISMA 指南》。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-19 DOI: 10.5041/RMMJ.10518
Jaime A Teixeira da Silva, Timothy Daly

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were elaborated to allow authors of such papers to identify quality articles for inclusion in their scholarly work. However, we have identified several issues that point to an over-reliance on the PRISMA guidelines. Firstly, we question the rigor of implementation by authors and the rigor of verification by peer reviewers and editors, and whether they have screened papers to ensure adherence to the PRISMA guidelines. Secondly, we have identified cases where the PRISMA criteria led to as much as 99.97% of the published literature being ignored, suggesting that valid publications meeting these criteria might be at risk of being ignored. Thirdly, we have noted that exclusion is not only a quantitative problem-it is also a qualitative one, since the screening procedure groups all non-conforming literature into one basket. Fourthly, we have noted that seven copies of the PRISMA guidelines exist. This being the case, which one should be cited? To replace over-reliance on PRISMA screening, we encourage authors, peer reviewers, and editors to publish systematic reviews and meta-analyses that respect the dual criteria of scientific plausibility and diversity of included papers.

系统综述和元分析首选报告项目(PRISMA)指南的制定是为了让此类论文的作者能够确定高质量的文章,以便纳入其学术著作。然而,我们发现了几个问题,表明对 PRISMA 指南的过度依赖。首先,我们质疑作者执行的严谨性以及同行评审员和编辑核查的严谨性,质疑他们是否对论文进行了筛选以确保遵守 PRISMA 指南。其次,我们发现在一些案例中,PRISMA 标准导致高达 99.97% 的已发表文献被忽略,这表明符合这些标准的有效出版物可能面临被忽略的风险。第三,我们注意到,排除不仅是一个量的问题,也是一个质的问题,因为筛选程序将所有不符合标准的文献都归到了一个篮子里。第四,我们注意到有七份 PRISMA 指南。既然如此,应该引用哪一份呢?为了取代对 PRISMA 筛选的过度依赖,我们鼓励作者、同行评审员和编辑在发表系统综述和荟萃分析时尊重科学合理性和纳入论文多样性的双重标准。
{"title":"Against Over-reliance on PRISMA Guidelines for Meta-analytical Studies.","authors":"Jaime A Teixeira da Silva, Timothy Daly","doi":"10.5041/RMMJ.10518","DOIUrl":"10.5041/RMMJ.10518","url":null,"abstract":"<p><p>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were elaborated to allow authors of such papers to identify quality articles for inclusion in their scholarly work. However, we have identified several issues that point to an over-reliance on the PRISMA guidelines. Firstly, we question the rigor of implementation by authors and the rigor of verification by peer reviewers and editors, and whether they have screened papers to ensure adherence to the PRISMA guidelines. Secondly, we have identified cases where the PRISMA criteria led to as much as 99.97% of the published literature being ignored, suggesting that valid publications meeting these criteria might be at risk of being ignored. Thirdly, we have noted that exclusion is not only a quantitative problem-it is also a qualitative one, since the screening procedure groups all non-conforming literature into one basket. Fourthly, we have noted that seven copies of the PRISMA guidelines exist. This being the case, which one should be cited? To replace over-reliance on PRISMA screening, we encourage authors, peer reviewers, and editors to publish systematic reviews and meta-analyses that respect the dual criteria of scientific plausibility and diversity of included papers.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions. 大麻和类风湿性关节炎:评估益处、风险和未来研究方向的范围综述。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10509
Nicole Paland, Haya Hamza, Antonina Pechkovsky, Miran Aswad, Dayana Shagidov, Igal Louria-Hayon

Rheumatoid diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia, are characterized by progressive inflammation in the musculoskeletal system, predominantly affecting the joints and leading to cartilage and bone damage. The resulting pain and ongoing degradation of the musculoskeletal system contribute to reduced physical activity, ultimately impacting quality of life and imposing a substantial socioeconomic burden. Unfortunately, current therapeutics have limited efficacy in slowing disease progression and managing pain. Thus, the development of novel and alternative therapies is imperative. Cannabinoids possess beneficial properties as potential treatments for rheumatoid diseases due to their anti-inflammatory and analgesic properties. Preclinical studies have demonstrated promising results in halting disease progression and relieving pain. However, there is a scarcity of patient clinical studies, and the available data show mixed results. Consequently, there are currently no established clinical recommendations regarding the utilization of cannabis for treating rheumatoid diseases. In this review, we aim to explore the concept of cannabis use for rheumatoid diseases, including potential adverse effects. We will provide an overview of the data obtained from preclinical and clinical trials and from retrospective studies on the efficacy and safety of cannabis in the treatment of rheumatoid diseases.

类风湿性疾病,包括类风湿性关节炎、骨关节炎和纤维肌痛,其特征是肌肉骨骼系统的进行性炎症,主要影响关节并导致软骨和骨骼损伤。由此产生的疼痛和肌肉骨骼系统的持续退化导致体力活动减少,最终影响生活质量并造成巨大的社会经济负担。不幸的是,目前的治疗方法在减缓疾病进展和控制疼痛方面的疗效有限。因此,开发新的替代疗法势在必行。大麻素由于其抗炎和镇痛特性,作为治疗类风湿性疾病的潜在药物具有有益的特性。临床前研究表明,在阻止疾病进展和缓解疼痛方面取得了有希望的结果。然而,患者临床研究很少,现有数据显示出喜忧参半的结果。因此,目前还没有关于使用大麻治疗类风湿性疾病的既定临床建议。在这篇综述中,我们旨在探讨大麻用于类风湿性疾病的概念,包括潜在的不良反应。我们将概述从大麻治疗类风湿性疾病的疗效和安全性的临床前和临床试验以及回顾性研究中获得的数据。
{"title":"Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions.","authors":"Nicole Paland, Haya Hamza, Antonina Pechkovsky, Miran Aswad, Dayana Shagidov, Igal Louria-Hayon","doi":"10.5041/RMMJ.10509","DOIUrl":"10.5041/RMMJ.10509","url":null,"abstract":"<p><p>Rheumatoid diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia, are characterized by progressive inflammation in the musculoskeletal system, predominantly affecting the joints and leading to cartilage and bone damage. The resulting pain and ongoing degradation of the musculoskeletal system contribute to reduced physical activity, ultimately impacting quality of life and imposing a substantial socioeconomic burden. Unfortunately, current therapeutics have limited efficacy in slowing disease progression and managing pain. Thus, the development of novel and alternative therapies is imperative. Cannabinoids possess beneficial properties as potential treatments for rheumatoid diseases due to their anti-inflammatory and analgesic properties. Preclinical studies have demonstrated promising results in halting disease progression and relieving pain. However, there is a scarcity of patient clinical studies, and the available data show mixed results. Consequently, there are currently no established clinical recommendations regarding the utilization of cannabis for treating rheumatoid diseases. In this review, we aim to explore the concept of cannabis use for rheumatoid diseases, including potential adverse effects. We will provide an overview of the data obtained from preclinical and clinical trials and from retrospective studies on the efficacy and safety of cannabis in the treatment of rheumatoid diseases.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.4,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Action Myoclonus Secondary to Donepezil: Case Report and Literature Review. 多奈哌齐继发动作性肌阵挛:病例报告和文献复习。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10510
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara

Movement disorders associated with donepezil have been only rarely reported. Herein, we describe an older woman who developed myoclonus secondary to donepezil. A 61-year-old female presented with brief involuntary twitching. The patient reported that she consulted a general practitioner about 1 month before due to memory complaints. A diagnosis of mild cognitive impairment was made. Donepezil was started. After 4 weeks, she presented to our emergency department due to significant twitching. Multifocal myoclonus was observed. These movements occurred during rest and voluntary movement. Laboratory exams and cerebrospinal fluid analysis were normal. A cranial computed tomography and brain magnetic resonance imaging were unremarkable. Electroencephalography did not show epileptic activity. Electromyography revealed burst durations varying between 50 and 100 ms. Diazepam intravenous was started, which improved her abnormal movement within 1 hour. On the next day, she developed the same clinical symptoms of presentation. Donepezil was discontinued, and clonazepam was started. The patient had a complete recovery from her myoclonus. To the authors' knowledge, there are six reports of myoclonus secondary to donepezil/galantamine. There is no report of rivastigmine-induced myoclonus. The most frequent presentation was multifocal myoclonus. The management was the discontinuation of the acetylcholinesterase inhibitor. All the individuals recovered within 3 weeks.

与多奈哌齐相关的运动障碍很少被报道。在此,我们描述了一位老年妇女,她发展为多奈哌齐继发性肌阵挛。一名61岁女性出现短暂的不自主抽搐。患者报告称,由于记忆问题,她在大约1个月前咨询了全科医生。诊断为轻度认知障碍。多涅普齐尔开始了。4周后,由于严重抽搐,她出现在我们的急诊科。观察到多灶性肌阵挛。这些运动发生在休息和自愿运动期间。实验室检查和脑脊液分析正常。颅骨计算机断层扫描和脑磁共振成像并不显著。脑电图没有显示癫痫活动。肌电图显示爆裂持续时间在50到100毫秒之间。开始静脉注射安定,这在1小时内改善了她的异常运动。第二天,她出现了同样的临床症状。多奈哌齐停用,氯硝西泮开始使用。病人的肌阵挛完全康复了。据作者所知,有6例多奈哌齐/加兰他敏继发性肌阵挛的报告。目前尚无利瓦斯汀诱发肌阵挛的报告。最常见的表现是多灶性肌阵挛。治疗方法是停用乙酰胆碱酯酶抑制剂。所有个体均在3周内康复。
{"title":"Action Myoclonus Secondary to Donepezil: Case Report and Literature Review.","authors":"Jamir Pitton Rissardo,&nbsp;Ana Letícia Fornari Caprara","doi":"10.5041/RMMJ.10510","DOIUrl":"10.5041/RMMJ.10510","url":null,"abstract":"<p><p>Movement disorders associated with donepezil have been only rarely reported. Herein, we describe an older woman who developed myoclonus secondary to donepezil. A 61-year-old female presented with brief involuntary twitching. The patient reported that she consulted a general practitioner about 1 month before due to memory complaints. A diagnosis of mild cognitive impairment was made. Donepezil was started. After 4 weeks, she presented to our emergency department due to significant twitching. Multifocal myoclonus was observed. These movements occurred during rest and voluntary movement. Laboratory exams and cerebrospinal fluid analysis were normal. A cranial computed tomography and brain magnetic resonance imaging were unremarkable. Electroencephalography did not show epileptic activity. Electromyography revealed burst durations varying between 50 and 100 ms. Diazepam intravenous was started, which improved her abnormal movement within 1 hour. On the next day, she developed the same clinical symptoms of presentation. Donepezil was discontinued, and clonazepam was started. The patient had a complete recovery from her myoclonus. To the authors' knowledge, there are six reports of myoclonus secondary to donepezil/galantamine. There is no report of rivastigmine-induced myoclonus. The most frequent presentation was multifocal myoclonus. The management was the discontinuation of the acetylcholinesterase inhibitor. All the individuals recovered within 3 weeks.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Release Our Hostages Now! 立即释放我们的人质!
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10507
Itamar Ashkenazi, Rafael Beyar, Shraga Blazer, Aaron Ciechanover, Karl L Skorecki
{"title":"Release Our Hostages Now!","authors":"Itamar Ashkenazi,&nbsp;Rafael Beyar,&nbsp;Shraga Blazer,&nbsp;Aaron Ciechanover,&nbsp;Karl L Skorecki","doi":"10.5041/RMMJ.10507","DOIUrl":"10.5041/RMMJ.10507","url":null,"abstract":"","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rambam Maimonides Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1